← Back to headlines
Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-3 Study of TALZENNA®
Pfizer Inc. has announced positive topline results from its Phase 3 TALAPRO-3 study of TALZENNA®, indicating successful outcomes for the drug.
25 Mar, 18:52 — 25 Mar, 18:52
Sources
Showing 1 of 1 sources
Related Stories
NASA Prepares to Launch Roman Space Telescope for Cosmic Mapping
20m ago
Scientists Investigate Herpes Virus Link to Mass Sardine Die-Off Off South Africa
19h ago
Partial Lunar Eclipse Captured by Stargazers Across Multiple Continents
1d ago
Global Observers Watch Partial Lunar Eclipse Covering Most of Moon
1d ago